Semaglutide
Peptide therapy: benefits, side effects, cost and protocols
C187H291N45O59
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for long-term weight management and to reduce the risk of major adverse cardiovascular events. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. Sold under the brand names Ozempic, Rybelsus, and Wegovy.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- Lowest listed
- $99/mo
- FDA status
- FDA-approved drug
- Evidence
- Strong Evidence
Price sheet
Semaglutide prices, lowest first
36 listings, $99 to $398 per month.
We may earn a commission at no extra cost to you. Disclosure
| Provider | Per month | Link |
|---|---|---|
Ageless Rx Microdosing Semaglutide / microdose weekly Research Use | $99Lowest | Visit |
Ageless Rx Semaglutide / injectable GLP-1 starting Research Use | $139 | Visit |
TeleHealth Med Compounded Semaglutide 503A CompoundedClinical | $147 | Visit |
Silhouette MD Semaglutide Injection 503A CompoundedClinical | $149 | Visit |
PeterMD Semaglutide Injection / 0.25mg-2.4mg weekly ClinicalRx | $149 | Visit |
Hims Wegovy® Pill 503A CompoundedClinical | $149 | Visit |
ReadyRx Compounded Semaglutide 503A CompoundedClinical | $179 | Visit |
TrimRx Oral Semaglutide 503A CompoundedClinical | $179 | Visit |
TrimRx Injectable Semaglutide 503A CompoundedClinical | $179 | Visit |
Clinic Secret Compounded Semaglutide / $49/week 503A CompoundedClinical | $196 | Visit |
ShedRX GLP-1 Lozenges 503A CompoundedClinical | $199 | Visit |
Hims Wegovy® Pen 503A CompoundedClinical | $199 | Visit |
ShedRX Compounded Semaglutide Injection 503A CompoundedClinical | $199 | Visit |
Calibrate Calibrate Semaglutide / weekly injection ClinicalRx | $199 | Visit |
BreezeMeds Semaglutide / weekly injection 503A CompoundedClinical | $199 | Visit |
Hims Ozempic® 503A CompoundedClinical | $199 | Visit |
ShedRX GLP-1 Liquid Drops 503A CompoundedClinical | $229 | Visit |
Alpha Hormones Semaglutide / weekly injection ClinicalRx | $249 | Visit |
Blue Sky MDOut of stock Semaglutide Weight Loss / weekly injection Clinical | $249 | Visit |
Direct Meds Semaglutide Oral Drops / sublingual 503A CompoundedClinical | $249 | Visit |
Henry Meds Oral Semaglutide / oral/sublingual ClinicalRx | $249 | Visit |
Better Life MedicalOut of stock Semaglutide / weekly injection Clinical | $259 | Visit |
Silhouette MD Semaglutide Oral 503A CompoundedClinical | $263 | Visit |
Belle HealthOut of stock Semaglutide / weekly injection ClinicalRx | $275 | Visit |
BrightMeds Semaglutide / weekly injection ClinicalRx | $289 | Visit |
Defy MedicalOut of stock Semaglutide Injection / 0.25mg-2.4mg weekly ClinicalRx | $289 | Visit |
Direct Meds Semaglutide / weekly injection 503A CompoundedClinical | $297 | Visit |
Henry Meds Compounded Semaglutide Injection / weekly injection ClinicalRx | $297 | Visit |
Prime Health Compounded Semaglutide 503A CompoundedClinical | $299 | Visit |
Willow Semaglutide Injectable 503A CompoundedClinical | $299 | Visit |
Hone HealthOut of stock Semaglutide Program / 0.25mg-2.4mg weekly ClinicalRx | $299 | Visit |
Willow Semaglutide Oral 503A CompoundedClinical | $299 | Visit |
ShedRXOut of stock Oral Semaglutide Tablets / legacy oral tablets; page 404 — Shed now sells Foundayo (orforglipron) separately 503A CompoundedClinical | $299 | Visit |
VivioMDOut of stock GLP-1 Tablets (Semaglutide) FDA BrandClinical | $299 | Visit |
BodyLogicMDOut of stock Semaglutide Program / weekly injection Research Use | $325 | Visit |
VivioMDOut of stock GLP-1 Injection (Semaglutide) FDA BrandClinical | $398 | Visit |
Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.
Who it's for
Who Semaglutide is usually considered for
- Weight loss
- Appetite suppression
- Glycemic control
- Metabolic health
Mechanism
How Semaglutide works
GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity for weight management.
Evidence
Key studies
6,156 papers on PubMed / 3,540 human trials
- 01
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
- 02
Lincoff AM, Brown-Frandsen K, Colhoun HM et al
N Engl J Med / Phase 3
- 03
Semaglutide reduced cardiovascular events in obese patients with cardiovascular disease but without diabetes
- 04
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
- 05
McGuire DK, Marx N, Mulvagh SL et al
N Engl J Med / Phase 3
- 06
Oral semaglutide reduced major adverse cardiovascular events vs placebo in high-risk type 2 diabetes
- 07
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial
- 08
McGuire DK, Busui RP, Deanfield J et al
Diabetes Obes Metab / Diabetes Obes Metab / Phase 3
- 09
SOUL trial design for assessing oral semaglutide effects on cardiovascular outcomes in type 2 diabetes with atherosclerotic disease and/or chronic kidney disease
- 10
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Compound
Semaglutide compound data
- Formula
- C187H291N45O59
- Mol. weight
- 4114 g/mol
- PubChem CID
- 56843331 ↗
- IUPAC
- 18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methyl-propanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-5-oxo-pentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(1S)-1-[[(1S)-1-benzyl-2-[[(1S,2S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[2-[[(1S)-1-(carboxymethylcarbamoyl)-4-guanidino-butyl]amino]-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]amino]-6-oxo-hexyl]amino]-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-1-carboxy-4-oxo-butyl]amino]-18-oxo-octadecanoic acid
FAQ
Semaglutide questions
What is SEMAGLUTIDE?
Semaglutide is the GLP-1 agonist that revolutionized weight loss treatment. Following FDA resolution of shortages in 2025 and subsequent compounding restrictions, research-grade semaglutide has seen significant demand increases.
How does SEMAGLUTIDE work?
GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves insulin sensitivity for weight management.
Is SEMAGLUTIDE legal to buy?
SEMAGLUTIDE requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.
Where can I buy SEMAGLUTIDE?
SEMAGLUTIDE is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.
What category does SEMAGLUTIDE belong to?
SEMAGLUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of SEMAGLUTIDE?
SEMAGLUTIDE has been studied for: Weight loss, Appetite suppression, Glycemic control, Metabolic health. GLP-1 classic; restricted compounding has increased research vendor demand.
News
Semaglutide in the news
Updates on Glucagon-Like Peptide-1 Receptor Agonists for Diabetes and Obesity - Pharmacy Times
Pharmacy Times / 5 days ago
Peptides are all over social media and the news. Here’s what to know about them. - Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health / 1 month ago
Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes - Cureus
Cureus / 6 months ago
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug - McGill University
McGill University / 6 months ago
Glucagon-like peptide-1 receptor agonist in large vessel occlusion treated by reperfusion therapy—a phase 2 randomized trial - Nature
Nature / 11 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Semaglutide?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.